photorefractive intrastromal crosslinking (PiXL)

Opportunities and challenges in the world of ophthalmology in 2018As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
PiXL appears promising for low myopiaThe use of epi-on photorefractive intrastromal cross linking reduced myopia by about 0.25 D in a small study; In a high-oxygen group, the effect averaged 1.25 D.
Crosslinking showing potential for refractive correction
Crosslinking showing potential for refractive correctionPhotorefractive intrastromal cross-linking is being developed for non-invasive correction of low refractive errors.